Evidence-Based Peptide Research

Unlock the Science of Peptides

Your trusted resource for comprehensive peptide guides, dosage calculators, and the latest research in biohacking and optimization.

50+

Peptide Guides

10K+

Monthly Readers

100%

Science-Backed

Latest Research

Peptide Articles

Deep dives into specific peptides, compounds, and biohacking agents.

View All Articles

Research

15 min read

Orforglipron: The Oral GLP-1 Pill That Could Change Everything — Data, Cost & Access

Orforglipron is a non-peptide oral GLP-1 agonist with no food restrictions and self-pay pricing starting at $149/month. Phase 3 shows 12.4% weight loss. FDA priority review expected 2026.

Research

13 min read

GLP-1 Medication Costs: Insurance, Savings Programs & the $149 Oral Option

GLP-1 medication costs vary from $149/month for orforglipron to over $1,350/month for Wegovy. Complete guide to insurance coverage, savings programs, LillyDirect, and every way to reduce costs.

Research

14 min read

CagriSema: The Amylin + GLP-1 Combination — Mechanism, Trial Results & FDA Timeline

CagriSema combines cagrilintide (amylin) and semaglutide (GLP-1) in a single weekly injection. Phase 3 trials show 22.7% weight loss. NDA filed December 2025, with FDA approval expected late 2026.

Research

12 min read

GLP-1 Side Effects Compared: What to Expect from Every Major Medication

Complete comparison of GLP-1 side effects across semaglutide, tirzepatide, CagriSema, retatrutide, and orforglipron. Learn what to expect, how to manage symptoms, and when to seek medical attention.

Research

16 min read

Retatrutide: The Triple Agonist Producing Record Weight Loss — Mechanism, Data & Outlook

Retatrutide is the first triple GIP/GLP-1/glucagon agonist. Phase 3 data shows up to 28.7% weight loss — the highest ever recorded. Learn about its mechanism, trial results, and projected timeline.

Research

19 min read